医药制造业参与价值链“双循环”的测度及其产业结构升级效应研究——以浙江省为例

财经论丛 ›› 2022, Vol. 38 ›› Issue (5): 14-23.

医药制造业参与价值链“双循环”的测度及其产业结构升级效应研究——以浙江省为例

陈锦其¹, 项莹², 陈奇远²

1.中共浙江省委党校发展战略研究所,浙江杭州 311121;
2.浙江财经大学数据科学学院,浙江杭州 310018

收稿日期:2021-06-27 出版日期:2022-05-10 发布日期:2022-05-09
通讯作者: 陈奇远(1996—),女,浙江杭州人,浙江财经大学数据科学学院硕士生。
作者简介:陈锦其(1979—),男,浙江慈溪人,中共浙江省委党校发展战略研究所副教授,博士;项莹(1982—),女,浙江杭州人,浙江财经大学数据科学学院教授,博士。
基金资助:
国家社会科学基金一般项目(18BTJ042);全国统计科学研究重点项目(2020LZ28)

Measurement of Pharmaceutical Manufacturing Industry's Participation in“Double Cycle” of Value Chain and Its Industrial Structure Upgrading Effect:A Case Study of Zhejiang Province

CHEN Jinqi¹, XIANG Ying², CHEN Qiyuan²

1. Institute of Development Strategy,Party School of Zhejiang Provincial Committee of CPC,Hangzhou 311121,China;
2. School of Data Sciences,Zhejiang University of Finance and Economics,Hangzhou 310018,China

Received:2021-06-27 Online:2022-05-10 Published:2022-05-09

摘要/Abstract

摘要： 本文从医药制造业参与全球价值链(GVC)和国内价值链(NVC)分工的视角出发,构建省际医药制造业参与价值链“双循环”测度框架,分析浙江医药制造业参与价值链“双循环”的测度及其产业结构升级效应。结果显示,相较于GVC分工,考察期内浙江医药制造业更多地参与了NVC分工,且药品制造业比医疗器械制造业在价值链分工上更具优势;在长三角地区的不同省份中,上海参与GVC分工程度最高,安徽参与NVC分工程度最高,浙江均处于中间位置。进一步的研究发现,改进前后的浙江医药制造业的影响力系数与感应度系数的差别较大,参与GVC分工可促进浙江药品制造业影响力系数的提高,而参与GVC和NVC分工并未引发浙江医疗器械制造业影响力系数和感应度系数的提高。浙江医药制造业的增加值增长主要依靠生产结构升级拉动,需求的拉动作用仍有待发挥。

关键词: 医药制造业, 双循环, 价值链分工, 产业结构升级

Abstract: From the perspective of the pharmaceutical manufacturing industry's participation in GVC and NVC, this paper builds a global and national value chain participation measurement frameworkthe dynamic change process of Zhejiang pharmaceutical manufacturing industry's participation in the “double cycle” of the value chain. On this basis, an empirical measurement of the industrial structure upgrade effect of Zhejiang pharmaceutical manufacturing industry's participation in the value chain is . The research results show that compared with the GVC, the pharmaceutical manufacturing industry of Zhejiang is more involved in the NVC, and the medicine manufacturing industry has more advantages in the value chain than the medical device manufacturing industry. different provinces in the Yangtze River Delta region that Shanghai has the highest degree of participation in GVC in pharmaceutical manufacturing, Anhui has the highest degree of participation in NVC, and Zhejiang is in the middle position. The effect of industrial structure changes indicates that the influence and inductance coefficients of pharmaceutical manufacturing industry are quite different before and after the improvement. Participating in the GVC has promoted the increase in the influence coefficient of medicine manufacturing industry. The growth of the added value of Zhejiang's pharmaceutical manufacturing industry is mainly driven by the upgrading of the production structure, and the demand-pull role still needs to be further exerted.

Key words: Pharmaceutical Manufacturing Industry, Double Cycle, the Value Chain, Industrial Structure Upgrading

中图分类号:

F223

陈锦其, 项莹, 陈奇远. 医药制造业参与价值链“双循环”的测度及其产业结构升级效应研究——以浙江省为例[J]. 财经论丛, 2022, 38(5): 14-23.

CHEN Jinqi, XIANG Ying, CHEN Qiyuan. Measurement of Pharmaceutical Manufacturing Industry's Participation in“Double Cycle” of Value Chain and Its Industrial Structure Upgrading Effect:A Case Study of Zhejiang Province[J]. Collected Essays on Finance and Economics, 2022, 38(5): 14-23.

参考文献

[1] Hummels D. L., Ishii J., Yi K. M. The Nature and Growth of Vertical Specialization in World Trade[J]. Journal of International Economics, 2001, 54(1): 5-96.
[2] Koopman R., Powers W., Wang Z., Wei S. J. Give Credit Where Credit is Due: Tracing Value Added in Global Production Chains[Z]. NBER Working Paper, 2010.
[3] Johnson R. C., Noguera G. Accounting for Intermediates: Production Sharing and Trade in Value Added[J]. Journal of International Economics, 2012, 86(2): 224-236.
[4] Wang Z., Wei S. J., Zhu K. F. Quantifying International Production Sharing at the Bilateral and Sector Levels[Z]. NBER Working Paper, 2013, No. 19677.
[5] Los B., Timmer M. P., Vries G. J. How Global are Global Value Chains? A New Approach to Measure International Fragmentation[J]. Journal of Regional Science, 2015, 55(1): 66-92.
[6] Wang Z., Wei S. J., Yu X. D., Zhu K. F. Measures of Participation in Global Value Chains and Global Business Cycles[Z]. NBER Working Paper, 2017, No. w23222.
[7] 苏庆义. 中国省级出口的增加值分解及其应用[J]. 经济研究, 2016, (1): 84-98.
[8] 倪红福, 夏杰长. 中国区域在全球价值链中的作用及其变化[J]. 财贸经济, 2016, (10): 87-101.
[9] 邵朝对, 苏丹妮. 全球价值链生产率效应的空间溢出[J]. 中国工业经济, 2017, (4): 94-114.
[10] 潘文卿, 李跟强. 中国区域的国家价值链与全球价值链:区域互动与增值收益[J]. 经济研究, 2018, (3): 171-186.
[11] 段玉婉, 杨翠红. 基于不同贸易方式生产异质性的中国地区出口增加值分解[J]. 世界经济, 2018, (4): 75-98.
[12] 李善同, 何建武, 刘云中. 全球价值链视角下中国国内价值链分工测算研究[J]. 管理评论, 2018, (5): 11-20.
[13] 王直, 魏尚进, 祝坤福. 总贸易核算法:官方贸易统计与全球价值链的度量[J]. 中国社会科学, 2015, (9): 108-127.
[14] 黎峰. 双重价值链嵌入下的中国省级区域角色——一个综合理论分析框架[J]. 中国工业经济, 2020, (1): 136-154.
[15] Meng B., Wang Z., Koopman R. How are Global Value Chains Fragment and Extended in China's Domestic Production Networks?[Z]. IDE Discussion Papers, 2013.
[16] 沈利生. 重新审视传统的影响力系数公式——评影响力系数公式的两个缺陷[J]. 数量经济技术经济研究, 2010, (2): 133-141.
[17] 张若雪. 全球价值链下我国产业结构升级研究[J]. 现代管理科学, 2016, (2): 45-47.